Ghent University Academic Bibliography

Your filters: cql: author="Spelman, Tim" or (type any "bookEditor issueEditor" and editor="Spelman, Tim")

Add to list
- Journal Article
- A1
- open access
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis : an MSBase registry sub-study

Helmut Butzkueven, Pamela Farr, Serkan Ozakbas, Cavit Boz, Tomas Kalincik, Lisa Taylor, Anneke Van Der Walt, Raed Alroughani, Katherine Buzzard, Olga Skibina, et al.

(2026) MULTIPLE SCLEROSIS AND RELATED DISORDERS. 106.
Add to list
- Journal Article
- A1
- open access
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis

Simona Toscano, Tim Spelman, Serkan Ozakbas, Raed Alroughani, Clara G. Chisari, Salvatore Lo Fermo, Alexandre Prat, Marc Girard, Pierre Duquette, Guillermo Izquierdo, et al.

(2025) NEUROTHERAPEUTICS. 22(2).
Add to list
- Journal Article
- A2
- open access
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants : real-world evidence from MSBase

Tim Spelman, Sara Eichau, Raed Alroughani, Serkan Ozakbas, Samia J Khoury, Francesco Patti, Eva Kubala Havrdova, Cavit Boz, Murat Terzi, Jens Kuhle, et al.

(2024) MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL TRANSLATIONAL AND CLINICAL. 10(2). p.1-13
Add to list
- Journal Article
- A1
- open access
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

David Levitz, Yi Chao Foong, Paul Sanfilippo, Tim Spelman, Louise Rath, Angie Roldan, Anoushka Lal, Mastura Monif, Vilija Jokubaitis, Serkan Ozakbas, et al.

(2024) THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 17.
Add to list
- Journal Article
- A1
- open access
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Anoushka P. Lal, Yi Chao Foong, Paul G. Sanfilippo, Tim Spelman, Louise Rath, David Levitz, Marzena Fabis-Pedrini, Matteo Foschi, Mario Habek, Tomas Kalincik, et al.

(2024) JOURNAL OF NEUROLOGY. 271. p.5813-5824
Add to list
- Journal Article
- A2
- open access
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis : results from the MSBase registry

Tim Spelman, Serkan Ozakbas, Raed Alroughani, Murat Terzi, Suzanne Hodgkinson, Guy Laureys (UGent) , Tomas Kalincik, Anneke Van Der Walt, Bassem Yamout, Jeannette Lechner-Scott, et al.

(2023) NEURODEGENERATIVE DISEASE MANAGEMENT. 13(4). p.215-221

Academic Bibliography

Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis : an MSBase registry sub-study

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants : real-world evidence from MSBase

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis : results from the MSBase registry

Contents

Support

Contact